Agendia

Landmark Long-Term Data from EORTC’s MINDACT Study Published in The Lancet Oncology

IRVINE, Calif. & AMSTERDAM–(BUSINESS WIRE)–Agendia, Inc., a world leader in precision oncology for breast cancer, today announced that long-term follow…

Read More »